MedTech Integrates 2022 Track 3
What will MedTech products look like in the future, and how can we accelerate their development?
Welcome and opening remarks
Now that we are no longer part of the EU, what steps should the UK take to innovate in the MedTech space?
MICHAEL YOUNG | Co-founder | Lindus Health
HUGH HARVEY | Managing Director | Hardian Health
RUSSELL PEARSON | Regulation and Policy Specialist, Software and AI, Innovation Devices | MHRA
TOM BEALE | Senior Regulatory Affairs Specialist | Agilent Technologies
ALEX SHEPPARD | Co-Founder & CEO | Vatic Health
CHARLOTTE LEE-SINCLAIR | Principal consultant and founder | Third Culture Ventures
Physical and functional testing of medical devices
Understanding the Pros and Cons of Utilising an Established Combinational Product Platform vs a Unique Combinational Product Platform when developing your product for market.
DAVID TUDBURY | Europe Vice President, Medical Device Testing Division | Smithers
ALEX COLE | Head Of Strategic Marketing | CPI
MICHAEL KIPPING | Director, Medical Technologies – EMEAA | Element Materials Technology
GARETH WYNNE | Director of Medical Device Physical Testing Operations | Smithers
BRENNAN MILES | Managing Consultant – Head of Drug Delivery | Team Consulting
You’ve got the look
Aesthetics are incredibly important in product design and usability. Are we designing with patients in mind?
MERI BECKWITH | Co-founder | Lindus Health
UMAIMA AHMAD | Co-founder and Chief Executive Officer | 52 North Health
TONI SCHNEIDER |Chief Operating Officer| Ostique
LUCY JUNG | Chief Executive | Charco Neurotech
RACHEL JONES | Senior Director, Patient Experience | Health Unlocked – part of CorEvitas LLC
With growing concerns on climate change and focus on sustainability, how are ensuring that med tech devices are durable and recyclable?
MIKE LEWIS | Professor of Life Science Innovation | Innovation Agency North West Coast
LUELLA TRICKETT | Director, Value & Access | Association of British HealthTech Industries
CHRISTOPHER POMFRETT | MedTech Evidence and Technical Director | Device Access UK
MICHELLE SULLIVAN | Head Of Public Affairs | Boston Scientific
JONATHAN CULLEN | Professor | University of Cambridge
Predicting the next pandemics
Do we have the technology and infrastructure to enable us to rapidly predict and respond to the next infectious disease pandemics?
BEVERLEY VAUGHAN | Innovation Hubs Director | ARISE
JOHN ALLAN | Business Development Director | Spatial Apps (UK) Ltd
JANET HEMINGWAY CBE | Founding Director | Infection Innovation Consortium
BEVERLEY ISHERWOOD | Partnership Lead | Medicines Discovery Catapult
GABRIELA MARTINEZ | Knowledge Transfer Manager, Life Sciences (Pharma/MedTech) | Innovate UK KTN